The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Interim results from the OPTIMAL trial: A phase II clinical trial of combination nivolumab, ipilimumab, and taxane in patients with untreated metastatic non-small cell lung cancer (NSCLC).
 
Jeffrey Melson Clarke
Consulting or Advisory Role - AstraZeneca; Guardant Health; Merck; NGM Biopharmaceuticals; Pfizer; Pfizer
Speakers' Bureau - Guardant Health; Merck
Research Funding - Abbvie; Adaptimmune; Array BioPharma; AstraZeneca; Bristol-Myers Squibb; Genentech/Roche; GlaxoSmithKline; medpacto; Moderna Therapeutics; Spectrum Pharmaceuticals
Travel, Accommodations, Expenses - AstraZeneca; Merck; NGM Biopharmaceuticals; Pfizer
(OPTIONAL) Uncompensated Relationships - Lung Cancer Initiative of North Carolina
 
Xiaofei F. Wang
No Relationships to Disclose
 
Lin Gu
No Relationships to Disclose
 
Marvaretta Miesha Stevenson
No Relationships to Disclose
 
Tom Stinchcombe
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo; EMD Serono; Foundation Medicine; G1 Therapeutics; Genentech/Roche; Lilly; Novartis; Pfizer; Takeda
Research Funding - Advaxis (Inst); AstraZeneca (Inst); Blueprint Medicines (Inst); Genentech/Roche (Inst); Merck (Inst); Regeneron (Inst); Takeda (Inst)
 
Sundhar Ramalingam
Honoraria - Bayer; Bayer
Research Funding - Exelixis
 
Scott Joseph Antonia
Consulting or Advisory Role - Achilles Therapeutics; Amgen; AstraZeneca; Bristol-Myers Squibb; Cellular Biomedicine Group; Celsius Therapeutics; GlaxoSmithKline; Memgen; Merck; RAPT Therapeutics; Samyang; Venn Therapeutics
 
Afreen Shariff
No Relationships to Disclose
 
Jennifer Garst
No Relationships to Disclose
 
Jeffrey Crawford
Consulting or Advisory Role - Amgen; AstraZeneca; BeyondSpring Pharmaceuticals; Coherus Biosciences; Enzychem Lifesciences; G1 Therapeutics; GlaxoSmithKline; Merck; Mylan; Pfizer; Roche; Spectrum Pharmaceuticals
Research Funding - AstraZeneca (Inst); Genentech (Inst); Helsinn Healthcare (Inst)
 
Neal E. Ready
Honoraria - Abbvie; AstraZeneca; Bristol-Myers Squibb; Celgene; G1 Therapeutics; Genentech; Merck
Consulting or Advisory Role - Abbvie; AstraZeneca; Bristol-Myers Squibb; G1 Therapeutics; Genentech; Merck; Roche
Speakers' Bureau - Bristol-Myers Squibb; Celgene
Research Funding - Merck
Expert Testimony - Bristol-Myers Squibb; Celgene